Dry Omega uses a blend of natural marine and plant oils for stability and freshness
When managing dry eye symptoms it is important to address all aspects of this multifactorial disease including ocular surface inflammation and resulting damage.1
The role of dietary modifications has been well documented in dry eye management including the role of essential fatty acids (EFAs) as an anti-inflammatory agent.2
If, like many dry eye specialists, you take this more holistic approach to alleviating symptoms then you need to know that with Dry Omega from Eye Nutrients, you are recommending a best-in-class supplement to your patient.
Dry Omega’s unique, balanced, sustainable and non esterified oil is produced from small fish and is free-from additives or concentrates.
The DHA omega fatty acids are mixed with natural marine and plant oils, making them more stable and effective for longer, with no fishy after-taste or side effects.
The addition of lemon gives the Dry Omega liquid a highly palatable citrus taste which can be added to everyday foods such as dressings.
Available in capsules or liquid format.
Contains three Omega-3 essential fatty acids
- EPA – helps reduce inflammation in dry eyes.
- DHA – helps rebuild damaged cells on the surface of the eye.
- DPA – a very strong anti-inflammatory to help soothe dry eyes.
Benefits of Dry Omega
Read the news on
Described as a “game-changer” and “like a hot stone massage for your eyes” by beauty editors, the multi-award winning Heated Eye Wand has three settings that work together to soothe, hydrate and revive dry, tired eyes.
For this episode of Glasklar Hub our host Nick Atkins will be taking a peek (or should that be peep?!) into a rapidly growing business in the dry eye space – Peep Club.
Bruder range of hot and cold compresses are indicated for MGD, blepharitis, dry eye and it offers one specifically for contact lens wearers.
Interested in using Dry Omega in your practice?
Contact us to find out more about Dry Omega and to order.
1. J Craig et al. TFOS DEWS II Definition and Classification Report. The Ocular Surface Volume 15, Issue 3, July 2017, 276-283
2. L. Jones et al. TFOS DEWS II Management and Therapy Report. The Ocular Surface. Volume 15, Issue 3, July 2017, 607-611